DAXOR CORP (DXR) Stock Price, Quote, News and Overview
NASDAQ:DXR - Nasdaq - US2394671034 - Common Stock - Currency: USD
DXR Quote, Performance and Key Statistics
NASDAQ:DXR (3/3/2025, 8:28:00 PM)
7.7001
+0.14 (+1.85%)
The current stock price of DXR is 7.7001 USD. In the past month the price increased by 0.2%. In the past year, price decreased by -2.53%.
DXR Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 30.03 | 243.21B | ||
| ISRG | INTUITIVE SURGICAL INC | 77.35 | 202.22B | ||
| BSX | BOSTON SCIENTIFIC CORP | 41.78 | 154.56B | ||
| SYK | STRYKER CORP | 32.39 | 150.54B | ||
| MDT | MEDTRONIC PLC | 17.66 | 120.92B | ||
| BDX | BECTON DICKINSON AND CO | 16.42 | 65.60B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.25 | 42.11B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 19.25 | 39.50B | ||
| IDXX | IDEXX LABORATORIES INC | 38.86 | 35.79B | ||
| RMD | RESMED INC | 26.37 | 34.24B | ||
| DXCM | DEXCOM INC | 52.12 | 33.59B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 18.05 | 24.78B |
Related stock screener links
About DXR
Company Profile
Daxor Corp. is a biotechnology company which develops and manufactures the BVA-100 blood volume analyzer, an instrument that measures human blood volume. The company is headquartered in New York City, New York. The firm has developed and marketed the Blood Volume Analyzer (BVA-100), the diagnostic blood test cleared by the food and drug administration (FDA) to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms. Over 65,000+ tests have been performed at hospital centers across the United States, enhancing hospital performance metrics in a range of surgical and medical conditions, including significantly reducing mortality and readmissions in heart failure and critical care. The company is also focused on advancing healthcare by enabling optimal fluid management with blood volume analysis. The company has several ongoing trials in the areas of heart failure treatment with support from the National Institutes of Health (NIH) and is under contract developing analyzers.
Company Info
DAXOR CORP
Suite 7120, 350 Fifth Avenue
New York City NEW YORK 10118 US
CEO: Joseph Feldschuh
Employees: 45
Company Website: https://www.daxor.com/
Investor Relations: http://www.daxor.com/investors/
Phone: 12122440555
DAXOR CORP / DXR FAQ
What is the stock price of DAXOR CORP today?
The current stock price of DXR is 7.7001 USD. The price increased by 1.85% in the last trading session.
What is the ticker symbol for DAXOR CORP stock?
The exchange symbol of DAXOR CORP is DXR and it is listed on the Nasdaq exchange.
On which exchange is DXR stock listed?
DXR stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for DAXOR CORP stock?
6 analysts have analysed DXR and the average price target is 23.84 USD. This implies a price increase of 209.64% is expected in the next year compared to the current price of 7.7001. Check the DAXOR CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is DAXOR CORP worth?
DAXOR CORP (DXR) has a market capitalization of 37.27M USD. This makes DXR a Nano Cap stock.
How many employees does DAXOR CORP have?
DAXOR CORP (DXR) currently has 45 employees.
What are the support and resistance levels for DAXOR CORP (DXR) stock?
DAXOR CORP (DXR) has a support level at 7.63 and a resistance level at 7.71. Check the full technical report for a detailed analysis of DXR support and resistance levels.
Should I buy DAXOR CORP (DXR) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of DXR, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of DXR, evaluating the profitability, health, valuation and growth aspects
- DAXOR CORP (DXR) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- DAXOR CORP (DXR) Sales and EPS estimates to see what analysts future expectations are.
- DAXOR CORP (DXR) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- DAXOR CORP (DXR) Insider and Institutional Ownership to learn about the owners and their transactions.
- DAXOR CORP (DXR) Stock Chart to make your own analysis
- DAXOR CORP (DXR) Latest news and press-releases to stay up to date.
Does DAXOR CORP (DXR) stock pay dividends?
DXR does not pay a dividend.
What is the Price/Earnings (PE) ratio of DAXOR CORP (DXR)?
The PE ratio for DAXOR CORP (DXR) is 22.65. This is based on the reported non-GAAP earnings per share of 0.34 and the current share price of 7.7001 USD. Check the full fundamental report for a full analysis of the valuation metrics for DXR.
What is the Short Interest ratio of DAXOR CORP (DXR) stock?
The outstanding short interest for DAXOR CORP (DXR) is 0.6% of its float. Check the ownership tab for more information on the DXR short interest.
DXR Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to DXR. When comparing the yearly performance of all stocks, DXR is a bad performer in the overall market: 69.45% of all stocks are doing better.
DXR Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to DXR. DXR may be in some trouble as it scores bad on both profitability and health.
DXR Financial Highlights
Over the last trailing twelve months DXR reported a non-GAAP Earnings per Share(EPS) of 0.34. The EPS decreased by -60.74% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 1093.32% | ||
| ROA | 4.91% | ||
| ROE | 5.17% | ||
| Debt/Equity | 0.05 |
DXR Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to DXR. The Buy consensus is the average rating of analysts ratings from 6 analysts.